← FDA Drug Approvals (Drugs@FDA)
ROMIDEPSIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2021-10-12
Drug application
- FDA Application #
ANDA206254- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROMIDEPSIN
- Generic name
- ROMIDEPSIN
- Active ingredients
- ROMIDEPSIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2021-10-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown